使用RNA复制缺陷策略的阿尔法病毒疫苗开发
Zherui Zhang1, Jie Huang2, Zhenye Li2
1Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430062, China.
Molecular therapy : the journal of the American Society of Gene Therapy
|September 3, 2025
概括
研究人员通过删除 nsP4 基因创建了一个安全的委内瑞拉马脑炎病毒 (VEEV) 候选疫苗. 这种复制缺陷的VEEV疫苗可以保护小鼠免受致命的挑战,为阿尔法病毒疫苗开发提供了一个有前途的平台.
科学领域:
- 病毒学
- 免疫学
- 疫苗学
背景情况:
- 阿尔法病毒是关节动物传播的重要病原体.
- 许多致病性阿尔法病毒属于风险组3,限制了疫苗的开发.
- 开发安全有效的阿尔法病毒疫苗至关重要.
研究的目的:
- 开发一种安全有效的RNA复制缺陷的alphavirus疫苗平台.
- 通过删除 nsP4 基因 (VEEV-△nsP4) 来设计委内瑞拉马脑炎病毒 (VEEV).
- 评估VEEV-nsP4的免疫性和保护功效.
主要方法:
- 通过删除完整的nsP4基因构建VEEV-nsP4.
- 使用表达nsP4的BHK细胞系 (BHKnsP4) 进行转补.
- 在小鼠模型中评估了病毒复制,与野生型VEEV的免疫相似性和保护性免疫力.
主要成果:
- VEEV-△nsP4仅在BHKnsP4细胞中复制,表明有条件的复制.
- 候选疫苗VEEV- △nsP4具有高度减弱性,并且在免疫学上与野生型VEEV相似.
- 一次剂量VEEV-nsP4保护小鼠免受致命的VEEV挑战.
- 对其他阿尔法病毒如CHIKV,WEEV和EEEV进行了验证.
结论:
- nsP4转补系统为开发具有RNA复制缺陷的阿尔法病毒疫苗提供了安全有效的平台.
- 这一策略大大促进了对高风险阿尔法病毒的疫苗开发.
- VEEV-nsP4代表了委内瑞拉马脑炎的有希望的疫苗候选者.
相关概念视频
01:29Viruses with RNA Genomes
114
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
114
01:26DNA Bacteriophages
140
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
140